Literature DB >> 23392130

Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis.

Joshua J Mooney1, Brett M Elicker2, Thomas H Urbania2, Misha R Agarwal1, Christopher J Ryerson3, Michelle Linh T Nguyen1, Prescott G Woodruff1, Kirk D Jones4, Harold R Collard1, Talmadge E King1, Laura L Koth5.   

Abstract

BACKGROUND: It is unknown if the radiographic fibrosis score predicts mortality in persistent hypersensitivity pneumonitis (HP) and if survival is similar to that observed in idiopathic pulmonary fibrosis (IPF) when adjusting for the extent of radiographic fibrosis.
METHODS: We reviewed records from 177 patients with HP and 224 patients with IPF whose diagnoses were established by multidisciplinary consensus. Two thoracic radiologists scored high-resolution CT (HRCT) scan lung images. Independent predictors of transplant-free survival were determined using a Cox proportional hazards analysis. Kaplan-Meier survival curves were constructed, stratified by disease as well as fibrosis score.
RESULTS: HRCT scan fibrosis score and radiographic reticulation independently predicted time to death or lung transplantation. Clinical predictors included a history of cigarette smoking, auscultatory crackles on lung examination, baseline FVC, and FEV1/FVC ratio. The majority of HP deaths occurred in patients with both radiographic reticulation and auscultatory crackles on examination, compared with patients with only one of these manifestations (P < .0001). Patients with IPF had worse survival than those with HP at any given degree of radiographic fibrosis (hazard ratio 2.31; P < .01).
CONCLUSIONS: Survival in patients with HP was superior to that of those with IPF with similar degrees of radiographic fibrosis. The combination of auscultatory crackles and radiographic reticulation identified patients with HP who had a particularly poor outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23392130     DOI: 10.1378/chest.12-2623

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  43 in total

1.  Utility of Bronchoalveolar Lavage and Transbronchial Biopsy in Patients with Hypersensitivity Pneumonitis.

Authors:  Traci N Adams; Chad A Newton; Kiran Batra; Muhanned Abu-Hijleh; Tyonn Barbera; Jose Torrealba; Craig S Glazer
Journal:  Lung       Date:  2018-06-29       Impact factor: 2.584

2.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

Review 3.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

4.  A diagnostic model for chronic hypersensitivity pneumonitis.

Authors:  Kerri A Johannson; Brett M Elicker; Eric Vittinghoff; Deborah Assayag; Kaïssa de Boer; Jeffrey A Golden; Kirk D Jones; Talmadge E King; Laura L Koth; Joyce S Lee; Brett Ley; Paul J Wolters; Harold R Collard
Journal:  Thorax       Date:  2016-05-31       Impact factor: 9.139

5.  Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Carley Demchuk; Steven Montner; Rekha Vij; Mary E Strek
Journal:  Respir Med       Date:  2016-03-21       Impact factor: 3.415

Review 6.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

7.  Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.

Authors:  Julie Morisset; Kerri A Johannson; Eric Vittinghoff; Carlos Aravena; Brett M Elicker; Kirk D Jones; Charlene D Fell; Helene Manganas; Bruno-Pierre Dubé; Paul J Wolters; Harold R Collard; Christopher J Ryerson; Brett Ley
Journal:  Chest       Date:  2016-11-03       Impact factor: 9.410

8.  Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis.

Authors:  Joseph Jacob; B J Bartholmai; S Rajagopalan; R Karwoski; S M Mak; W Mok; G Della Casa; K Sugino; S L F Walsh; A U Wells; D M Hansell
Journal:  Eur Radiol       Date:  2017-01-27       Impact factor: 5.315

9.  Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.

Authors:  Margaret L Salisbury; Meng Xia; Susan Murray; Brian J Bartholmai; Ella A Kazerooni; Catherine A Meldrum; Fernando J Martinez; Kevin R Flaherty
Journal:  Respir Med       Date:  2016-07-28       Impact factor: 3.415

10.  Derivation and Validation of a Diagnostic Prediction Tool for Interstitial Lung Disease.

Authors:  Janelle Vu Pugashetti; Aleksander Kitich; Shehabaldin Alqalyoobi; Anne-Catherine Maynard-Paquette; David Pritchard; Julia Graham; Noelle Boctor; Andrea Kulinich; Elyse Lafond; Elena Foster; Cesar Mendez; Saad Choudhry; Jean Chalaoui; Julie Morisset; Michael Kadoch; Justin M Oldham
Journal:  Chest       Date:  2020-03-14       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.